CLASS ACTION UPDATE for SPB, AVEO and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP


CLASS ACTION UPDATE for SPB, AVEO and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Thursday, April 11, 2019 6:54 PM

NEW YORK, NY / ACCESSWIRE / April 11, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.

Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) (NYSE: SPB)

Class Period: June 14, 2016 - April 25, 2018
Lead Plaintiff Deadline : May 6, 2019
Join the action: https://www.zlk.com/pslra-1/spectrum-brands-holdings-inc-loss-form?prid=1043&wire=1

About the lawsuit: During the class period, Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Spectrum had been self-inflicting the operational issues at its Ohio and Kansas facilities; (ii) these operational issues were, in fact, recurring in nature; (iii) these operational issues would continuously impact production, shipping levels and sales; and (iv) as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

To learn more about the Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) class action contact [email protected].

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)

Class Period: August 4, 2016 - January 31, 2019
Lead Plaintiff Deadline : April 26, 2019
Join the action: https://www.zlk.com/pslra-1/aveo-pharmaceuticals-inc-loss-form?prid=1043&wire=1

About the lawsuit: AVEO Pharmaceuticals, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the TIVO‑3 trial was inadequately designed to address the OS concerns regarding AVEO's lead candidate drug, tivozanib, from the TIVO-1 trial presented in June 2013; (ii) tivozanib had insufficient survival data to meet FDA approval following its initial 2013 rejection; (iii) this lack of sufficient survival data would put tivozanib at greater risk of delayed FDA approval; and (iv) as a result, AVEO's public statements were materially false and misleading at all relevant times.

To learn more about the AVEO Pharmaceuticals, Inc. class action contact [email protected].

Maiden Holdings, Ltd. (NASDAQGS: MHLD)

Class Period: March 4, 2014 - November 9, 2018
Lead Plaintiff Deadline : April 12, 2019
Join the action: https://www.zlk.com/pslra-1/maiden-holdings-ltd-loss-form?prid=1043&wire=1

The complaint alleges that during the Class Period, defendants misrepresented the quality and nature of Maiden's underwriting and risk management policies and practices and the risks of its reinsurance portfolio. In particular, defendants misleadingly claimed that they were subjecting AmTrust's insurance portfolio to robust analysis and cross-checks to ensure that the Company had appropriately priced the risk of reinsuring AmTrust's insurance portfolio. In truth, the Company had failed to employ sufficient underwriting and risk management protocols and had largely abdicated its responsibility to ensure that its AmTrust Reinsurance segment priced policies commensurate with the risk assumed by the Company.

To learn more about the Maiden Holdings, Ltd. class action contact [email protected].

You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP


SHARE ARTICLE